The FDA will decide whether to approve Replimune's RP1 virus for treating advanced melanoma later this month.
Recent research is the latest to suggest that UV nail polish dryers aren't harmless to our skin cells.
Several larger trials of ambroxol for Parkinson's are already underway.
The compressed gas in nitrous oxide canisters can reach temperatures as low as -40 degrees Fahrenheit.
The adult brain still carries stem cells that grow, divide, and eventually become new mature neurons.
A woman in her 50s died from a rare complication of the bacterial STI this spring, the latest in a recent spike of similar cases in the state.
New research has found that people who tuck into bed early tend to be more physically active the next day.
Gene therapy has been effective for young children with genetic hearing loss, but this is the first study to show promising results in older patients.
The 56-year-old woman was hospitalized with an infection along her left arm's joints, tendons, and skin.
Elon Musk bragged about sending the USAID through a "wood chipper" earlier this year.
People with lactose intolerance are more likely to experience nightmares and poorer sleep.
Alarming research challenges the widely held belief that vapes are safer than cigarettes.
People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.
The medical charity behind the controversial new plan says the benefits outweigh the risks.
A dreaded fungus known to inhabit tombs has been reconstituted as a treatment for leukemia and is performing as effectively as some FDA-approved drugs.
Exercise and diet play a big part in healthy aging, and breakthroughs in anti-aging medicine may not be too far off.
People taking Amgen's MariTide lost up to 20% of their body weight in a Phase II trial.
The vast majority of research has failed to show any link between thimerosal and autism or other neurological issues.
Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug on the market.
Ocutrx Technologies' HemoLucence can digitally visualize areas of the body covered by up to a quarter inch of human blood.
